Currently holds a position at Intra-Cellular Therapies Inc
Position | Company | Period |
---|---|---|
Executive Vice President, Chief Commercial Officer | Intra-Cellular Therapies Inc | Oct. 16, 2018 - |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2024-03-11 | 2024-03-11 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
1,313
-4.2%
66.8687,787 USD |
1,313 -4.2% | 66.86 | 87,787 USD | |
2024-03-11 | 2024-03-11 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
1,729
-5.3%
65.92113,976 USD |
1,729 -5.3% | 65.92 | 113,976 USD | |
2024-03-11 | 2024-03-11 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
4,303
-11.6%
65.11280,168 USD |
4,303 -11.6% | 65.11 | 280,168 USD | |
2024-03-11 | 2024-03-07 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
4,496
-13.1%
66.95301,007 USD |
4,496 -13.1% | 66.95 | 301,007 USD | |
2024-03-11 | 2024-03-07 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
8,636
-20.2%
66.37573,171 USD |
8,636 -20.2% | 66.37 | 573,171 USD | |
2024-02-27 | 2024-02-26 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
1,307
-4.2%
71.1893,032 USD |
1,307 -4.2% | 71.18 | 93,032 USD | |
2024-02-27 | 2024-02-26 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
2,341
-7.0%
70.70165,509 USD |
2,341 -7.0% | 70.70 | 165,509 USD | |
2024-02-27 | 2024-02-26 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
4,059
-10.9%
69.56282,344 USD |
4,059 -10.9% | 69.56 | 282,344 USD | |
2024-02-27 | 2024-02-26 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
200
-0.5%
68.0313,606 USD |
200 -0.5% | 68.03 | 13,606 USD | |
2024-02-05 | 2024-02-02 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
6,904
-18.9%
67.49465,951 USD |
6,904 -18.9% | 67.49 | 465,951 USD | |
2024-02-05 | 2024-02-02 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
4,956
-11.9%
66.67330,417 USD |
4,956 -11.9% | 66.67 | 330,417 USD | |
2023-11-08 | 2023-11-06 |
Intra-Cellular Therapies Inc
(ITCI)
|
S Sale |
15,639
-34.5%
55.02860,417 USD |
15,639 -34.5% | 55.02 | 860,417 USD | |
2023-11-08 | 2023-11-06 |
Intra-Cellular Therapies Inc
(ITCI)
|
S Sale |
26,754
-37.1%
55.981,497,734 USD |
26,754 -37.1% | 55.98 | 1,497,734 USD | |
2023-08-09 | 2023-08-07 |
Intra-Cellular Therapies Inc
(ITCI)
|
S Sale |
55,300
-54.9%
58.793,251,087 USD |
55,300 -54.9% | 58.79 | 3,251,087 USD | |
2023-03-30 | 2023-03-28 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
10,183
-18.3%
54.01549,984 USD |
10,183 -18.3% | 54.01 | 549,984 USD | |
2023-03-30 | 2023-03-28 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
5,421
-8.9%
54.86297,396 USD |
5,421 -8.9% | 54.86 | 297,396 USD | |
2023-03-13 | 2023-03-13 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
423
-0.7%
44.0518,633 USD |
423 -0.7% | 44.05 | 18,633 USD | |
2023-03-13 | 2023-03-13 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
3,335
-5.2%
45.10150,409 USD |
3,335 -5.2% | 45.10 | 150,409 USD | |
2023-03-13 | 2023-03-10 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
1,800
-3.0%
42.7476,932 USD |
1,800 -3.0% | 42.74 | 76,932 USD | |
2023-03-13 | 2023-03-10 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
6,750
-10.2%
43.50293,625 USD |
6,750 -10.2% | 43.50 | 293,625 USD | |
2023-03-03 | 2023-03-01 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
7,241
-12.8%
50.01362,122 USD |
7,241 -12.8% | 50.01 | 362,122 USD | |
2023-02-22 | 2023-02-21 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
635
-1.2%
48.9331,071 USD |
635 -1.2% | 48.93 | 31,071 USD | |
2023-02-22 | 2023-02-21 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
123
-0.2%
47.325,820 USD |
123 -0.2% | 47.32 | 5,820 USD | |
2023-02-22 | 2023-02-21 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
3,140
-5.6%
46.61146,355 USD |
3,140 -5.6% | 46.61 | 146,355 USD | |
2022-04-08 | 2022-04-08 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
14,885
-24.7%
65.14969,609 USD |
14,885 -24.7% | 65.14 | 969,609 USD | |
2022-04-08 | 2022-04-08 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
53,987
-47.3%
64.423,477,843 USD |
53,987 -47.3% | 64.42 | 3,477,843 USD | |
2022-04-08 | 2022-04-08 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
17,476
-13.3%
63.551,110,600 USD |
17,476 -13.3% | 63.55 | 1,110,600 USD | |
2022-02-25 | 2022-02-24 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
1,371
-2.9%
51.3370,373 USD |
1,371 -2.9% | 51.33 | 70,373 USD | |
2022-02-25 | 2022-02-24 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
3,875
-7.7%
52.03201,616 USD |
3,875 -7.7% | 52.03 | 201,616 USD | |
2022-02-25 | 2022-02-24 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
2,660
-5.0%
52.94140,820 USD |
2,660 -5.0% | 52.94 | 140,820 USD | |
2022-02-23 | 2022-02-22 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
4,607
-9.2%
54.84252,648 USD |
4,607 -9.2% | 54.84 | 252,648 USD | |
2022-02-23 | 2022-02-22 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
6,532
-11.6%
55.60363,179 USD |
6,532 -11.6% | 55.60 | 363,179 USD | |
2022-01-11 | 2022-01-10 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
4,252
-8.6%
40.09170,463 USD |
4,252 -8.6% | 40.09 | 170,463 USD | |
2022-01-11 | 2022-01-10 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
13,935
-21.9%
40.80568,548 USD |
13,935 -21.9% | 40.80 | 568,548 USD | |
2022-01-11 | 2022-01-10 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
2,761
-4.2%
41.74115,244 USD |
2,761 -4.2% | 41.74 | 115,244 USD | |
2021-10-19 | 2021-10-18 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
500
-1.1%
38.8819,440 USD |
500 -1.1% | 38.88 | 19,440 USD | |
2021-10-19 | 2021-10-18 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
1,958
-4.1%
39.4477,224 USD |
1,958 -4.1% | 39.44 | 77,224 USD | |
2021-10-19 | 2021-10-18 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
4,288
-8.2%
40.77174,822 USD |
4,288 -8.2% | 40.77 | 174,822 USD | |
2021-10-19 | 2021-10-18 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
6,702
-11.4%
41.49278,066 USD |
6,702 -11.4% | 41.49 | 278,066 USD | |
2021-02-22 | 2021-02-19 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
600
-1.3%
38.9023,340 USD |
600 -1.3% | 38.90 | 23,340 USD | |
2021-02-22 | 2021-02-19 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
4,584
-9.1%
39.26179,968 USD |
4,584 -9.1% | 39.26 | 179,968 USD | |
2021-01-12 | 2021-01-11 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
9,684
-19.7%
32.02310,082 USD |
9,684 -19.7% | 32.02 | 310,082 USD | |
2020-10-16 | 2020-10-16 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
6,792
-19.5%
26.80182,026 USD |
6,792 -19.5% | 26.80 | 182,026 USD | |
2019-10-17 | 2019-10-16 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
6,774
-50.4%
8.2555,886 USD |
6,774 -50.4% | 8.25 | 55,886 USD |